Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Alcohol Treatment Engagement in ALD Patients

NCT06269510 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT06269510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06269510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Alcohol Treatment Engagement in ALD Patients
Lead sponsor
Henry Ford Health System
Phase
Not applicable
Overall status
Recruiting
Start date
January 28, 2026
Completion date
February 28, 2030
Enrollment
268 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol-related liver disease, liver diseases